These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 9426205

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor.
    Yu HH, Zisch AH, Dodelet VC, Pasquale EB.
    Oncogene; 2001 Jul 05; 20(30):3995-4006. PubMed ID: 11494128
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma.
    Tanaka K, Hida T, Oya Y, Yoshida T, Shimizu J, Mizuno T, Kuroda H, Sakakura N, Yoshimura K, Horio Y, Sakao Y, Yatabe Y.
    Cancer; 2017 May 15; 123(10):1731-1740. PubMed ID: 28177518
    [Abstract] [Full Text] [Related]

  • 25. RET activation by germline MEN2A and MEN2B mutations.
    Borrello MG, Smith DP, Pasini B, Bongarzone I, Greco A, Lorenzo MJ, Arighi E, Miranda C, Eng C, Alberti L.
    Oncogene; 1995 Dec 07; 11(11):2419-27. PubMed ID: 8570194
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.
    Kim DW, Hwang JH, Suh JM, Kim H, Song JH, Hwang ES, Hwang IY, Park KC, Chung HK, Kim JM, Park J, Hemmings BA, Shong M.
    Mol Endocrinol; 2003 Jul 07; 17(7):1382-94. PubMed ID: 12738763
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells.
    Califano D, D'Alessio A, Colucci-D'Amato GL, De Vita G, Monaco C, Santelli G, Di Fiore PP, Vecchio G, Fusco A, Santoro M, de Franciscis V.
    Proc Natl Acad Sci U S A; 1996 Jul 23; 93(15):7933-7. PubMed ID: 8755580
    [Abstract] [Full Text] [Related]

  • 33. Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases.
    Hwang ES, Kim DW, Hwang JH, Jung HS, Suh JM, Park YJ, Chung HK, Song JH, Park KC, Park SH, Yun HJ, Kim JM, Shong M.
    Mol Endocrinol; 2004 Nov 23; 18(11):2672-84. PubMed ID: 15297606
    [Abstract] [Full Text] [Related]

  • 34. FLT3 receptors with internal tandem duplications promote cell viability and proliferation by signaling through Foxo proteins.
    Scheijen B, Ngo HT, Kang H, Griffin JD.
    Oncogene; 2004 Apr 22; 23(19):3338-49. PubMed ID: 14981546
    [Abstract] [Full Text] [Related]

  • 35. Rho-dependent and -independent tyrosine phosphorylation of focal adhesion kinase, paxillin and p130Cas mediated by Ret kinase.
    Murakami H, Iwashita T, Asai N, Iwata Y, Narumiya S, Takahashi M.
    Oncogene; 1999 Mar 18; 18(11):1975-82. PubMed ID: 10208419
    [Abstract] [Full Text] [Related]

  • 36. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.
    Eng C, Smith DP, Mulligan LM, Nagai MA, Healey CS, Ponder MA, Gardner E, Scheumann GF, Jackson CE, Tunnacliffe A.
    Hum Mol Genet; 1994 Feb 18; 3(2):237-41. PubMed ID: 7911697
    [Abstract] [Full Text] [Related]

  • 37. The high transforming potency of erbB-2 and ret is associated with phosphorylation of paxillin and a 23 kDa protein.
    Romano A, Wong WT, Santoro M, Wirth PJ, Thorgeirsson SS, Di Fiore PP.
    Oncogene; 1994 Oct 18; 9(10):2923-33. PubMed ID: 7916147
    [Abstract] [Full Text] [Related]

  • 38. Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival.
    De Vita G, Melillo RM, Carlomagno F, Visconti R, Castellone MD, Bellacosa A, Billaud M, Fusco A, Tsichlis PN, Santoro M.
    Cancer Res; 2000 Jul 15; 60(14):3727-31. PubMed ID: 10919641
    [Abstract] [Full Text] [Related]

  • 39. Multiple endocrine neoplasia syndromes revisited. Clinical, morphologic, and molecular features.
    DeLellis RA.
    Lab Invest; 1995 May 15; 72(5):494-505. PubMed ID: 7745945
    [No Abstract] [Full Text] [Related]

  • 40. EGF receptor signaling induces pointed P1 transcription and inactivates Yan protein in the Drosophila embryonic ventral ectoderm.
    Gabay L, Scholz H, Golembo M, Klaes A, Shilo BZ, Klämbt C.
    Development; 1996 Nov 15; 122(11):3355-62. PubMed ID: 8951052
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.